A new technology announced by ProScanRxPharma Inc., Grafoid Inc. and Calevia Inc. can selectively search and destroy cancerous prostate cells and destroy them with a flash of red light combining biotechnology and advanced graphene technologies to provide ground-breaking new medical technology.
Reaching this level of innovation requires massive mastery of several fields of science, an effort with massive commercial applications. This is about finding the Holy Grail of cancer therapy: destroying cancer cells without difficult surgery that may or may not eliminate all the cancerous cells, or death defying chemotherapy. For many years now, researchers have been looking at ways to use graphene in cancer therapy by providing a focused way to eliminate cancer cells.